StockData
Electra Therapeutics, Inc. logo

Electra Therapeutics, Inc. (ETRA) stock

ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.35+0.04 (+0.48%)

Close on Nov 17, 2026Market cap $524.94MP/E –Yield –

Electra Therapeutics cash

Cash and short-term investments held at the end of each period.

Electra Therapeutics's cash was $402.50M at Sep 30, 2026. For fiscal 2025 it was $86.52M.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$86.52M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$402.50M–
Q4 FY2025Dec 31, 2025$86.52M–

More Electra Therapeutics figures

See a number that looks wrong?